GXO Logistics, Inc. (GXO) SEC Filings & Earnings Calls
EquiReason read 20 GXO Logistics, Inc. SEC filings in the last 12 months. Latest: 8-K on 2026-08-20 — Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this report.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 5.6B
- P/E TTM
- 42.9
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
5 Aug 202610-QGXO reported Q2 2026 results with 4% revenue growth, stable margins, and strong liquidity, but operating income declined 13% due to higher costs.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $3.44B | +4% y/y |
| Net income · Q2-2026 | $27M | -4% y/y |
| Operating cash flow · H1-2026 | $202M | |
| Direct operating expense as % of revenue · Q2-2026 | 85.2% | |
| Operating income · Q2-2026 | $77M | -14% y/y |
| Cash and cash equivalents · 2026-06-30 | $769M | |
| Share repurchases · Q2-2026 | $16M |
Risks flagged
Divestiture loss risk
“Net loss on divestiture of business for the six months ended June 30, 2026, was $23 million and related to a further reduction of the estimated fair value of certain grocery contracts.” · word for word
Regulatory risk (historical)
“Regulatory matter for the six months ended June 30, 2025 was $65 million and related to the deductibility of value-added tax payments we made to certain third-party service providers, which was settled in 2025.” · word for word
4 Aug 20268-K · 2.02GXO reported Q2 2026 revenue of $3.4B (+4.3% YoY), new business wins up 34% to $410M, and maintained full-year guidance midpoints for adjusted EBITDA and EPS. Organic revenue grew 3.4%.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $3.40B | +3% y/y |
| Organic revenue growth · Q2-2026 | 3.4% | |
| Net income · Q2-2026 | $27M | -4% y/y |
| Diluted EPS · Q2-2026 | $0.22 | -4% y/y |
| Adjusted EBITDA · Q2-2026 | $219M | +3% y/y |
| Adjusted diluted EPS · Q2-2026 | $0.59 | +4% y/y |
| Cash flow from operations · Q2-2026 | $76M | +2433% y/y |
| Free cash flow · Q2-2026 | $12M | -128% y/y |
| New business wins · Q2-2026 | $410M | +34% y/y |
| Incremental 2026 revenue secured · FY2026 | $1.00B | +29% y/y |
Guidance
FY26 organic revenue growth 4-5%; adjusted EBITDA $945-965M (prev $935-975M); adjusted diluted EPS $2.95-3.15 (prev $2.90-3.20); FCF conversion 30-40%.
Guidance midpoints maintained; ranges narrowed slightly; strong backlog and pipeline support outlook.
Risks flagged
Net income declined slightly YoY despite revenue growth, indicating margin pressure from costs or mix.
“Net income $27M vs $28M in Q2 2025.”
High debt levels relative to cash flow; net debt $2.4B vs operating cash flow $76M in Q2.
“Total debt $3.2B, net debt $2.4B, operating cash flow $76M.”
6 May 202610-QRevenue $3.30B (+11% y/y); Net income (loss) $5M; Direct operating expense as % of revenue 85.1open
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $3.30B | +11% y/y |
| Net income (loss) · Q1-2026 | $5M | |
| Direct operating expense as % of revenue · Q1-2026 | 85.1% |
5 May 20268-K · 2.02Revenue $3.30B (+11% y/y); Organic revenue growth 4.1; Net income $5M; Guidance: Adjusted EBITDA guidance raised from $930-$970M to $935-$975M; Adjusted diluted EPS raised from $2.85-$3.15 to $2.90-$3.20earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $3.30B | +11% y/y |
| Organic revenue growth · Q1-2026 | 4.1% | |
| Net income · Q1-2026 | $5M | |
| Diluted earnings per share · Q1-2026 | $0.03 | |
| Adjusted EBITDA · Q1-2026 | $200M | +23% y/y |
| Adjusted diluted EPS · Q1-2026 | $0.50 | +72% y/y |
| Cash flow from operations · Q1-2026 | $31M | +7% y/y |
| Free cash flow · Q1-2026 | $-31M | |
| New business wins · Q1-2026 | $227M | |
| Sales pipeline · Q1-2026 | $2.70B |
Guidance
Adjusted EBITDA guidance raised from $930-$970M to $935-$975M; Adjusted diluted EPS raised from $2.85-$3.15 to $2.90-$3.20
Company raised full-year 2026 guidance for adjusted EBITDA and adjusted EPS, citing strong Q1 performance, record pipeline, and accelerating demand.
Risks flagged
Free cash flow remains negative in Q1, though improving year-over-year.
“free cash flow was a use of $31 million, compared with $48 million used for the first quarter 2025”
Adjusted EBITDA includes a $12.5M net year-over-year benefit from non-recurring items (early site exit, contract termination costs).
“Adjusted EBITDA for the quarter included a $12.5 million net year-over-year benefit, primarily from an early site exit and the timing of contract termination costs.”
22 Apr 2026DEF 14AProxy statement for 2026 annual meeting, disclosing executive compensation, board refreshment, and 2025 financial performance.open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $13.18B | +13% y/y |
| Organic Revenue Growth · FY2025 | 3.9% | |
| Operating Income · FY2025 | $245M | +12% y/y |
| Net Income · FY2025 | $36M | -74% y/y |
| Diluted EPS · FY2025 | $0.28 | |
| Adjusted EBITDA · FY2025 | $881M | +8% y/y |
| Cash Flow from Operations · FY2025 | $434M | |
| Free Cash Flow · FY2025 | $259M | |
| Sales Pipeline · FY2025 | $2.30B | |
| New Business Wins · FY2025 | $1.00B |
Guidance
Sales pipeline >$2.3B; targeting ~$60M cost synergies from Wincanton by end of 2026
Management expresses positive outlook with record pipeline and synergy targets, indicating accelerating growth and margin expansion.
Risks flagged
CEO and CFO transition risk
“2025 was a transition year for GXO. During the year, the Committee managed a Chief Executive Officer succession, a Chief Financial Officer transition, and other executive transitions” · word for word
Net income decline
“Net income of $36 million compared with $138 million in 2024” · word for word
Integration risk from Wincanton acquisition
“Early synergy initiatives were underway by year-end, with GXO targeting approximately $60 million in run-rate cost synergies by the end of 2026.” · word for word
25 Feb 202610-KRevenue $13.18B (+13% y/y); Net income $36M (-74% y/y); Operating cash flow $434M (-21% y/y)open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $13.18B | +13% y/y |
| Net income · FY2025 | $36M | -74% y/y |
| Operating cash flow · FY2025 | $434M | -21% y/y |
| Free cash flow · FY2025 | $110M |
Risks flagged
Regulatory and litigation expense
“Regulatory matter and litigation expense totaled $65 million in 2025, compared with $59 million in 2024. In 2025, we recorded $65 million of expense related to a regulatory matter regarding the deductibility of value-added tax payments we made to certain third-party service providers, which were challenged by the Italian authorities.” · word for word
Divestiture execution risk
“In June 2025, the CMA approved the Wincanton Acquisition, subject to the divestment of certain grocery contracts in the U.K. We expect to complete the Wincanton Divestment in 2026.” · word for word
10 Feb 20268-K · 2.02Revenue $3.50B (+8% y/y); Revenue $13.20B (+12% y/y); Net income $43M (-57% y/y); Guidance: Organic revenue growth 4-5%; Adjusted EBITDA $930-970M (up 8% at midpoint); Adjusted diluted EPS $2.85-3.15 (up 20% at midpoint)earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q4-2025 | $3.50B | +8% y/y |
| Revenue · FY2025 | $13.20B | +13% y/y |
| Net income · Q4-2025 | $43M | -57% y/y |
| Net income · FY2025 | $36M | -74% y/y |
| Adjusted EBITDA · Q4-2025 | $255M | +2% y/y |
| Adjusted EBITDA · FY2025 | $881M | +8% y/y |
| Adjusted diluted EPS · Q4-2025 | $0.87 | -13% y/y |
| Adjusted diluted EPS · FY2025 | $2.51 | -10% y/y |
| Free cash flow · Q4-2025 | $163M | +28% y/y |
| Free cash flow · FY2025 | $259M | +3% y/y |
Guidance
Organic revenue growth 4-5%; Adjusted EBITDA $930-970M (up 8% at midpoint); Adjusted diluted EPS $2.85-3.15 (up 20% at midpoint)
Guidance raised with organic revenue growth, EBITDA and EPS growth, supported by record new business wins and AI/robotics investments.
Risks flagged
Net income declined significantly due to non-cash charges or other items, but adjusted metrics show underlying profitability.
“Net income was $43 million, compared with $100 million for Q4 2024; full year $36M vs $138M.” · word for word
10 Feb 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Forward guidance subject to variability; reconciliation to GAAP not provided without unreasonable effort.
“Reconciliation of non-GAAP guidance to GAAP not available due to variability and complexity of reconciling items.”
29 Jan 20268-K · 5.02Annual base salary $300,900.00; Responsibility allowance $6,000.00; RSU grant date value $150,000.00open
Figures in the filing · each found in the filing text
| Annual base salary · 2026 | $300900.00 | |
| Responsibility allowance · 2026 | $6000.00 | |
| RSU grant date value · 2026 | $150000.00 |
Risks flagged
Key accounting leadership transition may introduce short-term operational risk, but internal appointment mitigates disruption.
“Resignation of CAO; interim appointment effective April 1, 2026; no disagreements reported.”
15 Dec 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Leadership transition risk at board level
“Resignation of Chairman; new chairman appointed with experience”
12 Dec 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Execution risk in scaling operations globally
“Newly created COO role to standardize global execution”
24 Nov 20258-K · 1.01, 2.03Unrestricted cash netting allowance $400Mopen
Figures in the filing · each found in the filing text
| unrestricted cash netting allowance · Q4-2025 | $400M |
Risks flagged
Covenant relief suggests potential leverage concerns; amendment may indicate financial flexibility need.
“Modification of leverage ratio calculation to include cash netting.”
6 Nov 202510-QGXO reported Q3 2025 revenue growth of 8% YoY and operating income growth of 46%, but net income for 9M was negative due to regulatory costs.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $3.40B | +8% y/y |
| Net Income · Q3-2025 | $60M | +71% y/y |
| Operating Income · Q3-2025 | $118M | +46% y/y |
| Direct Operating Expense as % of Revenue · Q3-2025 | 84.2% | |
| Revenue (9M) · 9M-2025 | $9.67B | +14% y/y |
| Net Income (9M) · 9M-2025 | $-7M |
Risks flagged
Regulatory Risk in Italy
“For the nine months ended September 30, 2025, we recorded $65 million of expense related to a regulatory matter for the deductibility of value-added tax payments made by us to certain third-party service providers challenged by the Italian authorities.” · word for word
Integration Risk from Wincanton Acquisition
“Transaction and integration costs for the nine months ended September 30, 2025 and 2024 were $50 million and $55 million, respectively and primarily related to the Wincanton Acquisition.” · word for word
4 Nov 20258-K · 2.02Revenue $3.40B (+8% y/y); Organic Revenue Growth 4; Net Income $60M (+71% y/y); Guidance: FY2025 organic revenue growth 3.5-6.5%; adjusted EBITDA $865M-$885M; adjusted diluted EPS $2.43-$2.63; free cash flow conversion 25-35%.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q3-2025 | $3.40B | +8% y/y |
| Organic Revenue Growth · Q3-2025 | 4.0% | |
| Net Income · Q3-2025 | $60M | +71% y/y |
| Adjusted EBITDA · Q3-2025 | $251M | +13% y/y |
| Diluted EPS · Q3-2025 | $0.51 | +82% y/y |
| Adjusted Diluted EPS · Q3-2025 | $0.79 | 0% y/y |
| Operating Cash Flow · Q3-2025 | $232M | +17% y/y |
| Free Cash Flow · Q3-2025 | $187M | +70% y/y |
| New Business Wins · Q3-2025 | $280M | +24% y/y |
| Cash and Cash Equivalents · Q3-2025 | $339M |
Guidance
FY2025 organic revenue growth 3.5-6.5%; adjusted EBITDA $865M-$885M; adjusted diluted EPS $2.43-$2.63; free cash flow conversion 25-35%.
GXO reaffirmed full-year 2025 guidance, citing record Q3 revenue, strong new business wins, and double-digit EBITDA growth.
Risks flagged
Integration risk from Wincanton acquisition; synergy realization on track but execution risk remains.
“The integration of Wincanton is progressing swiftly, with synergy realization on track.” · word for word
Macroeconomic uncertainty could impact customer demand and organic growth.
“Our guidance reflects current FX rates.” · word for word
29 Oct 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Departure of Chief Revenue Officer & President of Europe creates transition risk; new COO role may take time to become effective.
“Richard Cawston will depart from his employment as Chief Revenue Officer & President of Europe in March 2026”
GXO Logistics, Inc. — questions
- What did GXO Logistics, Inc. file recently?
- 20 SEC filings in the last 12 months. Latest: 8-K on 2026-08-20 — Reported the departure of a director or principal officer (CEO/CFO change); filed financial statements and exhibits with this report
Every figure on this page comes from GXO Logistics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.